Posts Tagged ‘032’
Receipt of MOUD before and after incarceration in Massachusetts State prisons, 2014-2019
Perceptions of extended-release buprenorphine among people who received medication for opioid use disorder in jail: a qualitative study
In this qualitative study, individuals who received XR-Buprenorphine while incarcerated reflect on their experience with the medication.
Read More“Expected to happen”: perspectives on post-release overdose from recently incarcerated people with opioid use disorder
Opioid-related overdose is the leading cause of death for people recently released from incarceration, however treatment with medications for opioid use disorder (MOUD) during incarceration can reduce the mortality risk. This study seeks to qualitatively analyze perceptions of post-release overdose risk from the perspectives of people who received MOUD while incarcerated in one of eight…
Read MoreAssociation of random and observed urine drug screening with long-term retention in opioid treatment programs
Diffusion of medications for opioid use disorder treatment in jail settings: a convergent mixed methods study of jail staff perspectives
Diversion of medications to treat opioid use disorder: Qualitative findings from formerly incarcerated adults in Massachusetts
Carceral officials often cite diversion of medication for opioid use disorder (MOUD) (e.g., buprenorphine) as a reason for not offering MOUD treatment in jails and prisons with little understanding of patient perspectives. We aimed to understand patient perceptions of medication diversion from jail-based MOUD programs and the factors that contribute to and reduce diversion. We…
Read MoreUse of Big Data and Ethical Issues for Populations with Substance Use Disorder
With expanding data availability and computing power, health research is increasingly relying on big data from a variety of sources. We describe a state-level effort to address aspects of the opioid epidemic through public health research, which has resulted in an expansive data resource combining dozens of administrative data sources in Massachusetts. The Massachusetts Public…
Read MoreHolyoke Early Access to Recovery and Treatment (HEART): A case study of a court-based intervention to reduce opioid overdose
The District Court in Holyoke, Massachusetts, is among the first courts nationwide to provide access to medications for opioid use disorder (MOUD) and other treatment. The program uses an innovative multisectoral approach to serve a primarily Latinx population living in communities of concentrated poverty with high opioid overdose rates. We document the origins, adaptations, and…
Read MoreCorrelates and Patterns in Use of Medications to Treat Opioid Use Disorder in Jail
Little is known about the correlates of use of medications to treat opioid use disorder (MOUD, ie, buprenorphine, methadone, naltrexone) offered in jails. We evaluated the implementation and outcomes of a MOUD program offered by 2 of the first jails nationwide to provide access to such care. At jail entry, 48.7% of individuals with opioid…
Read MoreCOVID-19 impact on opioid overdose after jail release in Massachusetts
Release from incarceration is a high-risk period for opioid overdose. Concern about COVID-19 spread in jails led to early releases; it is unknown whether pandemic era releases of persons with opioid use disorder (OUD) contributed to increases in community overdose rates. Observational data compared overdose rates three months after release among jailed persons with OUD…
Read More